Unknown

Dataset Information

0

Fluoxetine does not enhance the effect of perceptual learning on visual function in adults with amblyopia.


ABSTRACT: Amblyopia is a common visual disorder that is treatable in childhood. However, therapies have limited efficacy in adult patients with amblyopia. Fluoxetine can reinstate early-life critical period-like neuronal plasticity and has been used to recover functional vision in adult rats with amblyopia. We conducted a Phase 2, randomized (fluoxetine vs. placebo), double-blind, multicenter clinical trial examined whether or not fluoxetine can improve visual acuity in amblyopic adults. This interventional trial included 42 participants diagnosed with moderate to severe amblyopia. Subjects were randomized to receive either 20?mg fluoxetine (n?=?22) or placebo (n?=?20). During the 10-week treatment period, all subjects performed daily computerized perceptual training and eye patching. At the primary endpoint, the mean treatment group difference in visual acuity improvement was only 0.027 logMAR units (95% CI: -0.057 to 0.110; p?=?0.524). However, visual acuity had significantly improved from baseline to 10 weeks in both fluoxetine (-0.167 logMAR; 95% CI: -0.226 to -0.108; p?

SUBMITTER: Huttunen HJ 

PROVIDER: S-EPMC6110780 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Fluoxetine does not enhance the effect of perceptual learning on visual function in adults with amblyopia.

Huttunen Henri J HJ   Palva J Matias JM   Lindberg Laura L   Palva Satu S   Saarela Ville V   Karvonen Elina E   Latvala Marja-Leena ML   Liinamaa Johanna J   Booms Sigrid S   Castrén Eero E   Uusitalo Hannu H  

Scientific reports 20180827 1


Amblyopia is a common visual disorder that is treatable in childhood. However, therapies have limited efficacy in adult patients with amblyopia. Fluoxetine can reinstate early-life critical period-like neuronal plasticity and has been used to recover functional vision in adult rats with amblyopia. We conducted a Phase 2, randomized (fluoxetine vs. placebo), double-blind, multicenter clinical trial examined whether or not fluoxetine can improve visual acuity in amblyopic adults. This intervention  ...[more]

Similar Datasets

| S-EPMC5545606 | biostudies-literature
| S-EPMC10320034 | biostudies-literature
| S-EPMC7021554 | biostudies-literature
| S-EPMC4735338 | biostudies-literature
| S-EPMC8592429 | biostudies-literature
| S-EPMC4544188 | biostudies-literature
| S-EPMC8498040 | biostudies-literature
| S-EPMC6374144 | biostudies-literature
| S-EPMC2864603 | biostudies-literature
| S-EPMC6482054 | biostudies-literature